Background--The MMP (matrix metalloproteinase) family plays diverse and critical roles in directing vascular wall remodeling in atherosclerosis. Unlike secreted-type MMPs, a member of the membrane-type MMP family, MT1-MMP (membrane-type 1 MMP; MMP14), mediates pericellular extracellular matrix degradation that is indispensable for maintaining physiological extracellular matrix homeostasis. However, given the premature mortality exhibited by MT1-MMP-null mice, the potential role of the proteinase in atherogenesis remains elusive. We sought to determine the effects of both MT1-MMP heterozygosity and tissue-specific gene targeting on atherogenesis in APOE (apolipoprotein E)-null mice.
V ascular smooth muscle cells (VSMCs) constitute the major cellular component of the tunica media, where they play key roles in regulating vascular tone and blood flow. 1 Under physiological conditions, the number of VSMCs within the arterial wall is tightly controlled, as is arterial wall thickness. 1, 2 In marked contrast, during the progression of atherosclerosis, VSMCs proliferate and transition from a contractile to a synthetic phenotype, thereby depositing excess extracellular matrix (ECM) molecules that lead to arterial wall thickening and stiffening, namely, arteriosclerosis. 3, 4 However, the molecular mechanisms that underlie VSMC proliferation and arteriosclerosis during the pathological process of atherosclerosis remain largely undefined. ECM remodeling is mediated by members of the MMP (matrix metalloproteinase) gene family, a group of structurally related proteolytic enzymes that are broadly characterized as either secreted or membrane tethered. 5 Consistent with their potential roles in vascular wall pathology, recent studies have characterized the roles of secreted MMPs, particularly MMP-2, MMP-8, and MMP-13, in promoting atherogenesis or plaque rupture. [6] [7] [8] With regard to the membrane-tethered MMPs, MT1-MMP uniquely serves as a pericellular collagenase that contrast to almost all other MMP family members, in which gene targeting exerts only minor effects on mouse development, MT1-MMP-knockout animals display severe dwarfism, lipodystrophy, and premature lethality, underscoring the key roles played by MT1-MMP in maintaining tissue homeostasis. [10] [11] [12] Given the premature lethality of MT1-MMP-knockout mice, however, attempts to characterize the role of MT1-MMP in atherogenesis have been limited. Schneider et al used a bone marrow transplant system to transfer MT1-MMP-null bone marrow cells into atherogenic Ldlr À/À mice to assess the role of the proteinase when expressed by myeloid cells in atherogenesis. 13 The reconstitution of atherogenic mice with MT1-MMP-null bone marrow cells did not alter the size of the atheroma or the number of infiltrating macrophages but did result in increased collagen content within the atheromatous lesions. 13 Consequently, although myeloid cell-derived MT1-MMP appears to control collagen turnover, the role of MT1-MMP in regulating atherogenic responses in non-myeloid cell populations remains unknown. Despite the paucity of information regarding the role of MT1-MMP in atherogenesis, MT1-MMP heterozygous mice, which do not display any of the severe developmental phenotypes observed in the MT1-MMP-null mice, have been reported to display a protected status from both obesity induced by a high fat diet 14 and neointima formation secondary to carotid injury. 15 Given the attenuated responses of MT1-MMP heterozygous animals to pathologic stresses, we initially hypothesized that these mice might likewise be protected from hypercholesterolemic atherogenesis. Contrary to our expectations, we now report that atherogenesis is significantly enhanced in heterozygous Mmp14 +/À Apoe À/À mice. To determine the cellular mechanisms by which MT1-MMP limits the progression of atherogenesis, we extended our analyses to include newly characterized conditional knockout mice to selectively target MT1-MMP expression in adipose tissue, macrophages, or VSMCs in APOE (apolipoprotein E)-null mice. Unexpectedly, we found that MT1-MMP expressed by VSMCs, and not by either adipocytes or macrophages, exerts a profound protective effect against the progression of proliferative atherosclerotic lesions in Apoe À/À mice. Together, these results constitute the first example of MT1-MMP serving as an antiatherogenic enzyme by directly regulating VSMC function and proliferation in the in vivo setting. Csf1r-Cre, or of 1 mL/min, as described previously. 21 Arterial trees were carefully dissected to include the brachiocephalic, left common carotid, and subclavian arteries, as well as the descending thoracic and abdominal aortas with the bilateral iliac arteries. Adipose tissues attached to the arteries were carefully removed under a dissecting microscope. After Oil Red O staining and repeated washing in ethanol and water, aortic trees were pinned against a black background, and the aortic trees were digitally photographed under a dissecting microscope. 22 Oil Red O-positive areas were quantified as the percentage of plaque area per total arterial tree or abdominal aorta.
Material and Methods

Animals
Collagen Staining and Histologic Analysis
Sections were stained with hematoxylin and eosin and sirius red. 23 The atheroma area and vascular wall area were quantified in cross-sections using ImageJ software (National Institutes of Health), and the average plaque and vascular wall areas were determined. Immunostaining was performed using the ABC system. The primary antibodies used were rabbit polyclonal anti-a-smooth muscle actin (anti-a-SMA) antibody, anti-F4/80 antibody, and anti-Ki67 antibody.
Vascular Smooth Muscle Cells
Mouse aortic smooth muscle cells were isolated with collagenase digestion, as described by others. 24 Isolated primary mouse VSMCs were cultured in high-glucose DMEM with 10% FBS and passed twice before experiments. Mouse primary VSMCs immortalized with the SV40 large T antigen were purchased from ATCC. 25 
3-Dimensional Spheroid Culture
Cells (2910 4 ) were cultured as hanging droplets in a 384-well Perfecta3D hanging droplet plate (3D Biomatrix) for 48 hours before assays. 26 Cells were cultured in high-glucose DMEM with 10% FBS medium supplemented with 0.24% Methocel A4M (Dow).
Whole-Genome Expression Analysis
The total RNA was extracted from cultured primary VSMCs. Two independent pairs of samples were used for the DNA microarray experiments. Labeled cRNA was hybridized to Affymetrix Mouse Gene ST 2.1 strips at the University of Michigan DNA Sequencing Core. Expression values were calculated using a robust multiarray average. Probe sets that showed >2-fold difference between the groups with a minimal expression value >2 4 in at least 1 of the samples were chosen for further statistical analyses. Data analysis was performed with R version 3.1.1, and a heat map was created using the gplots package (R package version 2.17.0, http://CRAN.Rproject.org/package=gplots). Significant biological pathways represented by the differentially expressed genes were determined using PANTHER (http://pantherdb.org/).
Statistical Analyses
Values were expressed as meanAESEM. The distribution of weight, fat mass, cholesterol profile, fasting insulin, and glucose levels between 2 groups were analyzed using a 2-tailed, unpaired Student t test. To assess the differences in atherogenesis between the multiple groups, 2-way ANOVA was used, followed by a post hoc pairwise comparison using the Tukey procedure. P values <0.05 were considered significant.
Results
The Effect of the MT1-MMP Gene Dose on Fat
Mass and Dyslipidemia in APOE-Null Mice
We previously demonstrated that MT1-MMP heterozygosity renders mice resistant to obesity induced by a high fat diet.
14 Based on this finding, we hypothesized that the allelic reduction of the MT1-MMP gene would protect mice from hypercholesterolemic atherosclerosis, a disease process that is often associated with obesity in humans. 27 As such, we crossbred MT1-MMP heterozygous (Mmp14 Figure 2B ), suggesting that MT1-MMP heterozygosity promoted vascular wall arteriosclerosis along with plaque formation in the APOE-null background. MT1-MMP HT mice also displayed an apparent loss of a contractile phenotype (ie, loss of SMA staining) coupled with disrupted elastic lamina, which in turn elicited more complex and advanced atherosclerotic lesions ( Figure 2C and 2D ).
MT1-MMP Gene Targeting in VSMCs Accelerates Atherosclerosis Progression
Although MT1-MMP heterozygosity was found to promote atherogenesis, the cellular mechanisms underlying the aggravated atherogenesis were unclear. In obesity, perivascular adipose tissues play a key role in atherogenesis. 28 In contrast, dysfunctional VSMCs might also be responsible for inducing inflammatory atherogenesis. 4 Because MT1-MMP is highly expressed in both adipocytes 9, 10 mice frequently extended to femoral arteries with significant outward remodeling having been noted, in tandem with aneurysm formation in the iliac arteries ( Figure 3A and 3B ). In contrast, significant differences were not observed between Crenegative controls and the adipose-specific MT1-MMP deletion model ( Figure 3C and Figure S1 ), suggesting that the VSMCs are the primary cell type that mediates MT1-MMP-dependent modulation of atherogenesis progression.
The Loss of VSMC MT1-MMP Leads to Proliferative Atherosclerotic Lesions and Aneurysm Formation
After 12-week Western diet feeding, SM22a-Cre(+) Mmp14 Image quantification of the lesions confirmed an increased atheroma area ( Figure 4B ) and outward remodeling ( Figure 4C ), which were coupled with an increased number of proliferating VSMCs ( Figure 4D Figure S2 ). In vitro, MT1-MMPnull VSMCs displayed a flattened, spread shape with higher stress fiber formation ( Figure 5A ), whereas the expression of other MMPs (eg, MMP-2, MMP-8, MMP-9, MMP-13, and MT2-MMP [MMP15]), were not significantly different between control and MT1-MMP-deleted cells ( Figure S2 ). The Acta2 gene, which encodes a-SMA, was expressed equally in primary VSMCs isolated from SM22-Cre(À)Mmp14 F/F Apoe À/À and SM22-Cre(+)Mmp14 F/F Apoe À/À mice ( Figure S2 ). To gain further insight into the effects of MT1-MMP gene targeting in VSMCs, whole-genome transcriptome analysis was performed. Using a minimum 2-fold difference as a cutoff, 414 genes were found to be differentially expressed between the 2 groups (the top 70 genes are shown in Figure 5B , and all differentially expressed genes are listed in Table S1 ; the microarray data is available at NCBI Gene Expression Omnibus [GSE] as GSE100661). Interestingly, the genes upregulated in SM22a-Cre(+)Mmp14 
Discussion
MMP family members play a key role in ECM turnover in a wide variety of developmental and disease processes.
30
Among the collagen-degrading MMPs, secreted (MMP-3, MMP-8, MMP-13) and membrane-type MMPs (MT1-and MT2-MMP) display distinct temporospatial differences in their patterns of expression and activity. 9 Unlike other MMPs, MT1-MMP (MMP14) is the only family member whose activity is indispensable for postnatal development. 10, 11 Because of the premature morbidity and mortality displayed by MT1-MMPnull mice, the role of the proteinase in cardiovascular disease has remained elusive. To date, the only MT1-MMP-expressing cellular compartment tested in a mouse atherogenesis model was bone marrow-derived myeloid cells; however, no substantial impact on atheroma size was observed following bone marrow reconstitution with Mmp14 À/À cells. 13 In our study, we identified the critical role played by VSMC-derived MT1-MMP in regulating the progression of atherosclerotic lesions and the associated formation of vascular aneurysms. Previously, we demonstrated that MT1-MMP heterozygosity protects C57BL/6 mice from diet-induced adipose tissue expansion.
14 Similarly, in this study, heterozygous Mmp14
mice displayed a leaner phenotype relative to Mmp14 +/+ mice in an APOE-null background. Consistent with their leaner phenotype, MT1-MMP heterozygous mice displayed higher insulin sensitivity than WT mice. Given the metabolically improved status of Mmp14 +/À mice, we initially hypothesized that MT1-MMP heterozygosity would protect mice from hypercholesterolemic atherosclerosis, which is often associated with increased adiposity. Contrary to our expectations, MT1-MMP heterozygous APOE-null mice developed more extensive atherosclerotic lesions than MT1-MMP-sufficient APOE-null mice, suggesting a potentially beneficial role for MT1-MMP in limiting disease progression. The results also suggest that the inverse relationship observed between fat mass and atherosclerosis-the so-called obesity paradox in humans-may reflect the independent biological effects exerted by a cohort of modifier genes, including MT1-MMP, on adipose tissue and vascular function.
To define the cellular mechanisms by which MT1-MMP exerts its antiatherogenic effects, we embarked on a series of studies aimed at tissue-specific MT1-MMP gene targeting in APOE-null mice. In the early stages of our efforts, we focused on 2 cell types: adipocytes and VSMCs. We initially hypothesized that the loss of adipocyte MT1-MMP would modify atherogenesis via the potentially causal links that exist between adipose tissue and the vascular wall. 31 In APOEnull mice, however, we were unable to observe a significant impact on atherogenesis following gene targeting of adipocyte-derived MT1-MMP. In contrast, the SM22a-Cre-mediated loss of VSMC MT1-MMP strikingly aggravated atherosclerosis progression in APOE-null mice. Whole-genome transcriptome analyses indicated that a series of proinflammatory genes were upregulated in MT1-MMP-null VSMCs, a finding consistent with the proatherogenic phenotype of SM22a-Cre(+) Mmp14 Although increased collagen content within atheroma might be predicted to play a protective role against plaque rupture, collagen accumulation in arterial walls could also accentuate vascular sclerosis and stiffening. In turn, stiff and sclerotic blood vessels could increase luminal sheer stress, thereby increasing the chance of plaque rupture. In future studies, an assessment of hemodynamic changes and plaque instability in our model will be required to more accurately define the role of MT1-MMP in cardiovascular disease. Interestingly, in APOE-null mice, arterial wall stiffness is known to be increased through VSMC lysyl oxidase activity. 43 In turn, increased tissue stiffness could control VSMC proliferation through the activation of a mechanotransduction pathway, for example, YAP/TAZ transcription activity. 44 As such, we posit that the pathologic accumulation of ECM macromolecules secondary to the loss of MT1-MMP activity may further promote vascular wall rigidity in the APOE-null mice, leading to hyperproliferative vascular lesions and aneurysm formation. Given that we observed severe atherosclerosis and aneurysm formation in iliac and femoral arteries, site-specific increases in vascular wall thickening and arteriosclerosis are likely related to the distinct mechanical properties of vessel walls observed along the arterial tree.
elastic lamina compared with carotid arteries and thoracic aortas. 45 Together, differences in mechanical stress and ECM composition may render VSMCs in abdominal aortae and femoral arteries more vulnerable to atherogenic proliferation. Finally, it remains to be determined whether the inflammatory gene expression profile observed in MT1-MMP-null VSMCs is restricted to atherogenic milieu encountered in vivo. Interestingly, in our hands, the increase in inflammatory gene expression of MT1-MMP-null VSMCs was coupled with decreased mitochondrial activity (T. Akama, PhD, unpublished data, 2016). Furthermore, recent studies have demonstrated a critical role played by a VSMC phenotypic switch to macrophage-like cells in atherogenesis. 4 
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Ras association (RalGDS/AF- Figure S1. Arterial trees dissected from Cre(-), SM22α-Cre(+), and aP2-Cre(+) MMP14 F/F Apoe -/-male and female mice after a 12-week Western diet. 
